The answer, first. Both are graded animal-only, and both have very high community adoption. That combination is the single most common pattern on this market, and the honest answer to which is better is that the published human record cannot distinguish them, because neither has one. Anyone telling you one outperforms the other in people is reporting anecdote.
Side by side
The same two axes this site applies to every compound, with nothing added for the comparison.
| BPC-157 | TB-500 | |
|---|---|---|
| Clinical evidence | animal only | animal only |
| Community adoption | very high | very high |
| Category | healing | healing |
| Our summary | Gastric pentadecapeptide studied for tendon, ligament, and gut repair — almost entirely in animals. Human trial data remains close to zero. We grade the full evidence base in a dedicated article. | A synthetic fragment of thymosin beta-4 sold for injury recovery. The supporting evidence is animal and cell work — controlled human data is lacking. |
| Full file | BPC-157 → | TB-500 → |
What actually separates them
Three differences that hold up against the published record, rather than against marketing.
What neither can tell you
- What is in the vial. A comparison between molecules says nothing about the contents of a specific lot. Only a certificate of analysis does, and most cover fewer measures than buyers assume — start with how to read a COA.
- A dose. This site describes what published protocols used and never prescribes.
- Which is right for you. That is a clinical question about an individual, and nothing here is medical advice.
Questions we get
Is BPC-157 or TB-500 better for healing?
Neither can be shown better from the published human record, because neither has one. Both are graded animal-only on this site: their evidence comes from rodent injury models, and no published randomised human trial supports either for the uses they are marketed for. Any ranking between them reflects anecdote rather than measurement.
Should they be stacked together?
This site does not give protocol advice. What can be said is that no published human trial exists for either compound individually, so no evidence exists for the combination either. The absence is the finding.
Why are they so popular if the evidence is animal-only?
Popularity and evidence are separate axes here, and this pair is where they diverge most. Both carry very high community adoption alongside an animal-only clinical grade. That divergence is the reason this site grades the two things separately rather than folding them into one score.